Endogenous GLP1 and GLP1 analogue alter CNS responses to palatable food consumption

Brain reward-system activation in response to anticipation and consumption of palatable food is altered by glucagon-like peptide-1 receptor activation in humans

(2015) L. van Bloemendaal et al.   DIABETES OBESITY & METABOLISM

Endogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes

(2015) Jennifer S. ten Kulve et al.   DIABETOLOGIA

Expression and Distribution of Glucagon-Like Peptide-1 Receptor mRNA, Protein and Binding in the Male Nonhuman Primate (Macaca mulatta) Brain

(2015) Kristy M. Heppner et al.   ENDOCRINOLOGY

GLP-1 Receptor Activation Modulates Appetite- and Reward-Related Brain Areas in Humans

(2014) L. van Bloemendaal et al.   DIABETES

The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss

(2014) Anna Secher et al.   JOURNAL OF CLINICAL INVESTIGATION

Neuronal GLP1R mediates liraglutide’s anorectic but not glucose-lowering effect

(2014) Stephanie Sisley et al.   JOURNAL OF CLINICAL INVESTIGATION

Food related processes in the insular cortex

(2013) Sabine Frank et al.   Frontiers in Human Neuroscience

A novel high-sensitivity electrochemiluminescence (ECL) sandwich immunoassay for the specific quantitative measurement of plasma glucagon

(2012) John H. Sloan et al.   CLINICAL BIOCHEMISTRY

Leptin therapy in type 2 diabetes

(2012) B. P. Cummings   DIABETES OBESITY & METABOLISM

Food and drug cues activate similar brain regions: A meta-analysis of functional MRI studies

(2012) D.W. Tang et al.   PHYSIOLOGY & BEHAVIOR

Effects of Exenatide on Measures of  -Cell Function After 3 Years in Metformin-Treated Patients With Type 2 Diabetes

(2011) M. C. Bunck et al.   DIABETES CARE

Circulating glucose levels modulate neural control of desire for high-calorie foods in humans

(2011) Kathleen A. Page et al.   JOURNAL OF CLINICAL INVESTIGATION

GSK1614343, a Novel Ghrelin Receptor Antagonist, Produces an Unexpected Increase of Food Intake and Body Weight in Rodents and Dogs

(2011) Vivian J.A. Costantini et al.   NEUROENDOCRINOLOGY

Liraglutide, a once-daily human glucagon-like peptide 1 analogue, provides sustained improvements in glycaemic control and weight for 2 years as monotherapy compared with glimepiride in patients with type 2 diabetes

(2010) A. Garber et al.   DIABETES OBESITY & METABOLISM

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

(2009) D. Russell-Jones et al.   DIABETOLOGIA

Imaging of Brain Dopamine Pathways

(2009) Gene-Jack Wang et al.   Journal of Addiction Medicine

Endogenous Glucagon-Like Peptide-1 Slows Gastric Emptying in Healthy Subjects, Attenuating Postprandial Glycemia

(2009) Adam M. Deane et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)

(2009) John B Buse et al.   LANCET

Evidence that Intestinal Glucagon-Like Peptide-1 Plays a Physiological Role in Satiety

(2008) Diana L. Williams et al.   ENDOCRINOLOGY

Modulation of taste sensitivity by GLP-1 signaling

(2008) Yu-Kyong Shin et al.   JOURNAL OF NEUROCHEMISTRY

Dissociating the Role of the Orbitofrontal Cortex and the Striatum in the Computation of Goal Values and Prediction Errors

(2008) T. A. Hare et al.   JOURNAL OF NEUROSCIENCE

Widespread reward-system activation in obese women in response to pictures of high-calorie foods

(2008) Luke E. Stoeckel et al.   NEUROIMAGE

Relation Between Obesity and Blunted Striatal Response to Food Is Moderated by TaqIA A1 Allele

(2008) E. Stice et al.   SCIENCE